A new orchestration approach, called Orchestral, is betting that enterprises and researchers want a more integrated way to ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, ...

Condé Nast Traveler readers believe this major US city is the end-all-be-all for shopping destinations in the country.